Applied Clinical Trials
The developed markets of North America and Europe together saw approximately 81% of the Phase I trial share in 2013 which is a 6% increase from 2012. Trials
Dr. J. Fred Pritchard, PhD
Advertisement
Dr. Pritchard ?is the Vice President, Global Drug Development, with Celerion, Raleigh-Durham, North Carolina.
Articles by Dr. J. Fred Pritchard, PhD
Advertisement
Latest Updated Articles
Is South Korea the Next Emerging Early Phase Destination?January 29th 2015
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Design Flaws Trial Simulations Surface That Traditional Planning Misses
2
ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval
3
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
4
Quantifying the Financial Value of RBQM: Q&A with Sylviane de Viron, CluePoints, and Abigail Dirks, Tufts CSDD
5